Concordia Healthcare Corp (TSE:CXR) had its price target reduced by research analysts at RBC Capital from C$81.00 to C$73.50 in a report released on Friday, StockTargetPrices.com reports. The brokerage presently has an “outperform” rating on the stock. RBC Capital’s price target indicates a potential upside of 90.17% from the stock’s current price.
Concordia Healthcare Corp (TSE:CXR) traded up 2.35% during mid-day trading on Friday, hitting $39.56. The stock had a trading volume of 1,600,460 shares. The firm has a 50-day moving average of $36.54 and a 200-day moving average of $42.61. The stock has a market cap of $2.01 billion and a P/E ratio of 282.57. Concordia Healthcare Corp has a 52-week low of $28.61 and a 52-week high of $117.75.